Source:http://linkedlifedata.com/resource/pubmed/id/11073948
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-5-23
|
pubmed:abstractText |
The c-myb proto-oncogene product (c-Myb) is a sequence-specific DNA-binding protein that functions as a transcriptional activator. The transcriptional coactivator CREB-binding protein (CBP) binds via its KIX domain to the activation domain of c-Myb and mediates c-Myb-dependent transcriptional activation. CBP possesses intrinsic histone acetyltransferase activity, and can acetylate not only histones but also certain transcriptional factors such as GATA1 and p53. Here we demonstrate that the C/H2 domain of CBP, which is critical for the acetyltransferase activity, also directly interacts with the negative regulatory domain (NRD) of c-Myb. Consistent with this observation, CBP acetylated c-Myb in vitro at Lys(438) and Lys(441) within the NRD. In addition, CBP acetylated c-Myb in vivo not only at the sites found in this study but also at the p300-induced acetylation sites reported recently. Replacement of lysine by arginine at all of these sites dramatically decreased the trans-activating capacity of c-Myb. The results of transcriptional activation assays with c-Myb acetylation site mutants suggested that acetylation of c-Myb at each of these five sites synergistically enhances c-Myb activity. Mutations of these acetylation sites reduced the strength of the interaction between c-Myb and CBP. Thus, acetylation of c-Myb by CBP increases the trans-activating capacity of c-Myb by enhancing its association with CBP. These results demonstrate a novel molecular mechanism of regulation of c-Myb activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CREB-Binding Protein,
http://linkedlifedata.com/resource/pubmed/chemical/CREBBP protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Lysine,
http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myb,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3674-82
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11073948-Acetylation,
pubmed-meshheading:11073948-Amino Acid Motifs,
pubmed-meshheading:11073948-CREB-Binding Protein,
pubmed-meshheading:11073948-Humans,
pubmed-meshheading:11073948-Lysine,
pubmed-meshheading:11073948-Nuclear Proteins,
pubmed-meshheading:11073948-Proto-Oncogene Proteins c-myb,
pubmed-meshheading:11073948-Trans-Activators,
pubmed-meshheading:11073948-Transcriptional Activation,
pubmed-meshheading:11073948-Transfection,
pubmed-meshheading:11073948-Tumor Cells, Cultured
|
pubmed:year |
2001
|
pubmed:articleTitle |
Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation.
|
pubmed:affiliation |
Laborartory of Molecular Genetics, RIKEN Tsukuba Institute and the CREST (Core Research for Evolutional Science and Technology) Research Project of JST (Japan Science and Technology Corporation), 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|